Announced
Synopsis
Kemin Industries, a a global ingredient manufacturer, agreed to acquire Bactana, a biotechnology company. Financial terms were not disclosed. "Compelled by curiosity, we are reinforcing our dedication to developing novel solutions that support metabolism, immune function, and overall well-being by combining Bactana's cutting-edge research with our existing expertise. This acquisition aligns with our long-term vision to explore emerging technologies in intestinal health and further strengthen our position as an industry leader," Kimberly Nelson, Kemin President.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite
Bidder Team (2)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy